SEI Investments’s OptimizeRx OPRX Stock Holding History

SEI Investments’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237K	Sell	41,424 -57,209	-58%	-$329K	﹤0.01%	2977
2026 Q1	$619K	Buy	98,633 +44,844	+83%	+$416K	﹤0.01%	2583
2025 Q4	$659K	Buy	+53,789	New	+$879K	﹤0.01%	2382
2022 Q3	–	Sell	-29,154	Closed	-$799K	–	2709
2022 Q2	$799K	Buy	29,154 +13,124	+82%	+$389K	﹤0.01%	1915
2022 Q1	$604K	Sell	16,030 -6,345	-28%	-$281K	﹤0.01%	2003
2021 Q4	$1.39M	Sell	22,375 -21,529	-49%	-$1.63M	﹤0.01%	1722
2021 Q3	$3.76M	Buy	43,904 +11,224	+34%	+$704K	0.01%	1231
2021 Q2	$2.02M	Buy	32,680 +2,875	+10%	+$146K	﹤0.01%	1517
2021 Q1	$1.4M	Buy	+29,805	New	+$1.44M	﹤0.01%	1615

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

SEI Investments's OPRX Position: Q2 2026 in Review

SEI Investments reduced its OptimizeRx (OPRX) stake by 58% in Q2 2026, selling an estimated $329K and leaving 41,424 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2977.

SEI Investments first reported a position in OPRX in Q1 2021 and has held it in 9 quarters since. The position peaked at $3.76M in Q3 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

SEI Investments held 41,424 shares of OptimizeRx worth $237K as of Q2 2026.
SEI Investments sold 57,209 OptimizeRx shares in Q2 2026, an estimated $329K.
OptimizeRx made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2977 holding.
SEI Investments first reported a position in OptimizeRx in Q1 2021 and has held it in 9 quarters since.
SEI Investments's OptimizeRx position peaked at $3.76M in Q3 2021.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.